RU2017108909A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2017108909A3 RU2017108909A3 RU2017108909A RU2017108909A RU2017108909A3 RU 2017108909 A3 RU2017108909 A3 RU 2017108909A3 RU 2017108909 A RU2017108909 A RU 2017108909A RU 2017108909 A RU2017108909 A RU 2017108909A RU 2017108909 A3 RU2017108909 A3 RU 2017108909A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14306352.7 | 2014-09-02 | ||
| EP14306352 | 2014-09-02 | ||
| PCT/EP2015/070082 WO2016034642A1 (en) | 2014-09-02 | 2015-09-02 | Isoquinolinone derivatives useful in the treatment of cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2017108909A RU2017108909A (ru) | 2018-10-03 |
| RU2017108909A3 true RU2017108909A3 (enExample) | 2018-12-13 |
| RU2690853C2 RU2690853C2 (ru) | 2019-06-06 |
Family
ID=51494243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2017108909A RU2690853C2 (ru) | 2014-09-02 | 2015-09-02 | Производные изохинолинона, полезные для лечения рака |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9944641B2 (enExample) |
| EP (1) | EP3189051A1 (enExample) |
| JP (1) | JP2017525734A (enExample) |
| CN (1) | CN106795154B (enExample) |
| BR (1) | BR112017003651A2 (enExample) |
| MX (1) | MX2017002544A (enExample) |
| RU (1) | RU2690853C2 (enExample) |
| WO (1) | WO2016034642A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018009938A1 (en) * | 2016-07-08 | 2018-01-11 | Rigel Pharmaceuticals, Inc. | Tyrosine kinase inhibitors |
| CN106699608A (zh) * | 2016-12-26 | 2017-05-24 | 常州大学 | 一种含有强吸电子基团的苯胍及其盐的制备方法 |
| CN111683976B (zh) | 2018-02-05 | 2022-11-18 | 生物辐射实验室股份有限公司 | 具有阴离子交换-疏水混合模式配体的色谱树脂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2783B1 (en) * | 2005-09-30 | 2014-03-15 | نوفارتيس ايه جي | Compounds 2-Amino-7, 8-dihydro-6H-Bayredo (3,4-D) Pyrimidine-5-Ones |
| EP2100894A1 (en) * | 2008-03-12 | 2009-09-16 | 4Sc Ag | Pyridopyrimidines used as Plk1 (polo-like kinase) inhibitors |
| WO2012102985A1 (en) | 2011-01-24 | 2012-08-02 | Glaxosmithkline Llc | Isoquinoline compounds and methods for treating hiv |
| WO2013041539A1 (en) | 2011-09-20 | 2013-03-28 | F. Hoffmann-La Roche Ag | Imidazopyridine compounds, compositions and methods of use |
| AR089776A1 (es) * | 2012-01-23 | 2014-09-17 | Boehringer Ingelheim Int | 5,8-dihidro-6h-pirazolo[3,4-h]quinazolinas como inhibidores de igf-1r/ir |
| CN104271576A (zh) * | 2012-02-23 | 2015-01-07 | 艾伯维公司 | 激酶的吡啶并嘧啶酮抑制剂 |
| EP3388436B1 (en) * | 2013-03-15 | 2020-08-12 | Dana-Farber Cancer Institute, Inc. | Pyrimido-diazepinone compounds and methods of treating disorders |
-
2015
- 2015-09-02 WO PCT/EP2015/070082 patent/WO2016034642A1/en not_active Ceased
- 2015-09-02 JP JP2017512003A patent/JP2017525734A/ja active Pending
- 2015-09-02 BR BR112017003651A patent/BR112017003651A2/pt not_active IP Right Cessation
- 2015-09-02 RU RU2017108909A patent/RU2690853C2/ru not_active IP Right Cessation
- 2015-09-02 MX MX2017002544A patent/MX2017002544A/es unknown
- 2015-09-02 US US15/507,941 patent/US9944641B2/en not_active Expired - Fee Related
- 2015-09-02 CN CN201580047253.7A patent/CN106795154B/zh not_active Expired - Fee Related
- 2015-09-02 EP EP15762963.5A patent/EP3189051A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN106795154A (zh) | 2017-05-31 |
| US9944641B2 (en) | 2018-04-17 |
| RU2017108909A (ru) | 2018-10-03 |
| MX2017002544A (es) | 2017-07-19 |
| BR112017003651A2 (pt) | 2017-12-05 |
| US20170240544A1 (en) | 2017-08-24 |
| WO2016034642A1 (en) | 2016-03-10 |
| CN106795154B (zh) | 2019-07-05 |
| RU2690853C2 (ru) | 2019-06-06 |
| JP2017525734A (ja) | 2017-09-07 |
| EP3189051A1 (en) | 2017-07-12 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20200903 |